A. Licci

发表

Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)

C. Basso, V. Ranieri, M. Meschiari, 2020, Clinical Microbiology and Infection.

A Rare Disease But Not Too Much in Times of Globalization

R. Montironi, R. Mazzucchelli, A. Licci, 2017 .

In Vitro Activities of Tritrpticin Alone and in Combination with Other Antimicrobial Agents against Pseudomonas aeruginosa

G. Scalise, A. Giacometti, O. Cirioni, 2006, Antimicrobial Agents and Chemotherapy.

In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection

J. Łukasiak, W. Kamysz, G. Scalise, 2005, Peptides.

In Vitro Activity of the Histatin Derivative P-113 against Multidrug-Resistant Pathogens Responsible for Pneumonia in Immunocompromised Patients

J. Łukasiak, W. Kamysz, G. Scalise, 2005, Antimicrobial Agents and Chemotherapy.

THE CATHELICIDIN-DERIVED TRITRPTICIN ENHANCES THE EFFICACY OF ERTAPENEM IN EXPERIMENTAL RAT MODELS OF SEPTIC SHOCK

V. Saba, R. Ghiselli, G. Scalise, 2006, Shock.

LL-37 Protects Rats against Lethal Sepsis Caused by Gram-Negative Bacteria

M. Rocchi, V. Saba, R. Ghiselli, 2006, Antimicrobial Agents and Chemotherapy.

Listeria monocytogenes meningitis in an immunocompromised patient.

S. Barocci, A. Mancini, E. Petrelli, 2015, The new microbiologica.

Amphibian peptides prevent endotoxemia and bacterial translocation in bile duct–ligated rats*

W. Kamysz, V. Saba, R. Ghiselli, 2006, Critical care medicine.

In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients.

W. Kamysz, G. Scalise, A. Giacometti, 2005, International journal of antimicrobial agents.

In Vitro Activity and Killing Effect of Citropin 1.1 against Gram-Positive Pathogens Causing Skin and Soft Tissue Infections

J. Łukasiak, W. Kamysz, G. Scalise, 2005, Antimicrobial Agents and Chemotherapy.

Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis.

J. Łukasiak, W. Kamysz, V. Saba, 2005, Journal of Infectious Diseases.

In Vitro Activities of the Lipopeptides Palmitoyl (Pal)-Lys-Lys-NH2 and Pal-Lys-Lys Alone and in Combination with Antimicrobial Agents against Multiresistant Gram-Positive Cocci

M. Okrój, W. Kamysz, G. Scalise, 2006, Antimicrobial Agents and Chemotherapy.

In-Vitro Activity of the Synthetic Protegrin IB-367 Alone and in Combination with Antifungal Agents Against Clinical Isolates of Candida spp.

J. Łukasiak, W. Kamysz, F. Barchiesi, 2007, Journal of chemotherapy.

Comparative Efficacies of Quinupristin-Dalfopristin, Linezolid, Vancomycin, and Ciprofloxacin in Treatment, Using the Antibiotic-Lock Technique, of Experimental Catheter-Related Infection Due to Staphylococcus aureus

M. Provinciali, V. Saba, R. Ghiselli, 2005, Antimicrobial Agents and Chemotherapy.

RNAIII-INHIBITING PEPTIDE IN COMBINATION WITH THE CATHELICIDIN BMAP-28 REDUCES LETHALITY IN MOUSE MODELS OF STAPHYLOCOCCAL SEPSIS

V. Saba, R. Ghiselli, M. Zanetti, 2006, Shock.

Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection

V. Saba, R. Ghiselli, M. Zanetti, 2006, Peptides.

Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection

J. Łukasiak, W. Kamysz, V. Saba, 2006, Peptides.

In Vitro Activity and Killing Effect of Uperin 3.6 against Gram-Positive Cocci Isolated from Immunocompromised Patients

W. Kamysz, G. Scalise, A. Giacometti, 2005, Antimicrobial Agents and Chemotherapy.

Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection.

J. Łukasiak, W. Kamysz, V. Saba, 2007, JPEN. Journal of parenteral and enteral nutrition.

Predictors of Severe Respiratory Failure in Hospitalized Patients with SARS-CoV-2 Infection: Development and Validation of a Prediction Model (PREDI-CO Study)

V. Ranieri, M. Meschiari, C. Mussini, 2020, SSRN Electronic Journal.

In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics.

W. Kamysz, G. Scalise, A. Giacometti, 2005, The Journal of antimicrobial chemotherapy.

RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.

V. Saba, R. Ghiselli, G. Scalise, 2006, The Journal of infectious diseases.

RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.

V. Saba, R. Ghiselli, G. Scalise, 2006, The Journal of infectious diseases.